Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis ; volume:19 ; number:1 ; day:6 ; month:11 ; year:2024 ; pages:1-14 ; date:12.2024
Journal of cardiothoracic surgery ; 19, Heft 1 (6.11.2024), 1-14, 12.2024

Creator: Abdelaziz, Ahmed
Atta, Karim
Hafez, Abdelrahman H.
Elsayed, Hanaa
Ibrahim, Ahmed A.
Abdelaziz, Mohamed
Kadhim, Hallas
Mechi, Ahmed
Elaraby, Ahmed
Ezzat, Mahmoud
Fadel, Ahmed
Nouh, Abdullah
Ibrahim, Rahma AbdElfattah
Ellabban, Mohamed Hatem
Bakr, Ali
Nasr, Ahmed
Suppah, Mustafa

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13019-024-03046-6

URN: urn:nbn:de:101:1-2501242113455.574939044133

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:35 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Abdelaziz, Ahmed
Atta, Karim
Hafez, Abdelrahman H.
Elsayed, Hanaa
Ibrahim, Ahmed A.
Abdelaziz, Mohamed
Kadhim, Hallas
Mechi, Ahmed
Elaraby, Ahmed
Ezzat, Mahmoud
Fadel, Ahmed
Nouh, Abdullah
Ibrahim, Rahma AbdElfattah
Ellabban, Mohamed Hatem
Bakr, Ali
Nasr, Ahmed
Suppah, Mustafa
SpringerLink (Online service)

Other Objects (12)

A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions

5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs

Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis

Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario

Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions

Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients

Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches

Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis

Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis

A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions

5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs

Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis

Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario

Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions

Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients

Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches

Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis

Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis

A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions

5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs

Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis

Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario

Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions

Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients

Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches

Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis

Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Drug-coated balloons versus drug-eluting stents in patients with in-stent restenosis: An updated meta-analysis with trial sequential analysis

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions

5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs

Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis

Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario

Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions

Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients

Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches

Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis

Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis

A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions

5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs

Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis

Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario

Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions

Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients

Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches

Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis

Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis

A comparison between drug-eluting stent implantation and drug-coated balloon angioplasty in patients with left main bifurcation in-stent restenotic lesions

Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions

5-Year outcomes of drug-coated balloons for peripheral artery in-stent restenosis, long lesions, and CTOs

Rotarex®S rotational atherectomy combined with drug-coated balloon angioplasty for treating femoropopliteal artery in-stent restenosis

Drug-coated balloon treatment for Femoropopliteal artery disease: The IN.PACT Global study de novo in-stent restenosis imaging cohort

In-stent restenosis of drug-eluting stents: clinical presentation and outcomes in a real-world scenario

Clinical Outcome of Paclitaxel-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation for the Treatment of Coronary Drug-Eluting Stent In-Stent Chronic Total Occlusion

Comparison between drug-coated balloons and drug-eluting stents in very small coronary artery interventions

Drug-coated balloons versus drug-eluting stents for coronary de novo lesions in dialysis patients

Drug-coated balloon versus drug-eluting stent for femoropopliteal total occlusions: intraluminal versus subintimal approaches

Analysis of the incidence and influencing factors associated with binary restenosis of target lesions after drug-coated balloon angioplasty for patients with in-stent restenosis

Effect of diabetes mellitus on long-term outcomes after repeat drug-eluting stent implantation for in-stent restenosis

Related objects

Reset password